Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release

被引:39
作者
Efentakis, A [1 ]
Koligliati, S [1 ]
Vlachou, A [1 ]
机构
[1] Univ Athens, Fac Pharm, Dept Pharmaceut Technol, GR-15771 Athens, Greece
关键词
pulsatile release tablets; lag time; diclofenac sodium; ketoprofen; swellable polymers; erosion;
D O I
10.1016/j.ijpharm.2005.12.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this investigation a novel oral pulsatile drug delivery system based on a core-in-cup dry coated tablet, where the core tablet surrounded on the bottom and circumference wall with inactive material, is proposed. The system consists of three different parts, a core tablet, containing the active ingredient, an impermeable outer shell and a top cover layer-barrier of a soluble polymer. The core contained either diclofenac sodium or ketoprofen as model drugs. The impermeable coating cup consisted of cellulose acetate propionate and the top cover layer of hydrophilic swellable, materials, such as polyethylene oxide, sodium alginate or sodium carboxymethyl cellulose. The effect of the core, the polymer characteristics and quantity at the top cover layer, on the lag time and drug release was investigated. The results show that the system release of the drug after a certain lag tirne generally due to the erosion of the top cover layer. The quantity of the material, its characteristics (viscosity, swelling, gel layer thickness) and the drug solubility was found to modify lag time and drug release. The lag time increased when the quantity of top layer increased, whereas drug release decreased. The use of sodium carboxymethyl cellulose resulted in the greatest swelling, gel thickness and lag time, but the lowest drug release from the system. Polyethylene oxide showed an intermediate behaviour while, the sodium alginate exhibited the smallest swelling, gel thickness and the shortest lag time, but the fastest release. These findings suggest that drug delivery can be controlled by manipulation of these formulations. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 24 条
[1]   Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate [J].
Bettini, R ;
Catellani, PL ;
Santi, P ;
Massimo, G ;
Peppas, NA ;
Colombo, P .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :383-391
[2]   INFLUENCE OF MEDIUM ON DISSOLUTION-EROSION BEHAVIOR OF NA CARBOXYMETHYLCELLULOSE AND ON VISCOELASTIC PROPERTIES OF GELS [J].
BONFERONI, MC ;
ROSSI, S ;
FERRARI, F ;
BERTONI, M ;
CARAMELLA, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (01) :41-48
[3]   RHEOLOGICAL BEHAVIOR OF HYDROPHILIC POLYMERS AND DRUG RELEASE FROM ERODIBLE MATRICES [J].
BONFERONI, MC ;
CARAMELLA, C ;
SANGALLI, ME ;
CONTE, U ;
HERNANDEZ, RM ;
PEDRAZ, JL .
JOURNAL OF CONTROLLED RELEASE, 1992, 18 (03) :205-212
[4]   Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles [J].
Bussemer, T ;
Bodmeier, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 267 (1-2) :59-68
[5]   DRUG DIFFUSION FRONT MOVEMENT IS IMPORTANT IN DRUG-RELEASE CONTROL FROM SWELLABLE MATRIX TABLETS [J].
COLOMBO, P ;
BETTINI, R ;
MASSIMO, G ;
CATELLANI, PL ;
SANTI, P ;
PEPPAS, NA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (08) :991-997
[6]   A NEW IBUPROFEN PULSED RELEASE ORAL DOSAGE FORM [J].
CONTE, U ;
COLOMBO, P ;
LAMANNA, A ;
GAZZANIGA, A ;
SANGALLI, ME ;
GIUNCHEDI, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (14-16) :2583-2596
[7]  
DETHLEFSEN U, 1985, MED KLIN, P80
[8]   Swelling of hydroxypropyl methylcellulose matrix tablets .1. Characterization of swelling using a novel optical imaging method [J].
Gao, P ;
Meury, RH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :725-731
[9]   Swelling of hydroxypropyl methylcellulose matrix tablets .2. Mechanistic study of the influence of formulation variables on matrix performance and drug release [J].
Gao, P ;
Skoug, JW ;
Nixon, PR ;
Ju, TR ;
Stemm, NL ;
Sung, KC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (07) :732-740
[10]  
ISHIDO R, 1992, CHEM PHARM BULL, V40, P3041